High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is common in patients with inflammatory bowel disease (IBD). This study evaluated the prevalence of NAFLD and the associated risk factors among IBD patients who received anti-tumor necrosis factor (TNF) therapy. METHODS: Adult IBD patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Likhitsup, Alisa, Dundulis, Jason, Ansari, Shaya, Patibandla, Sruthi, Hutton, Colleen, Kennedy, Kevin, Helzberg, John H., Chhabra, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686093/
https://www.ncbi.nlm.nih.gov/pubmed/31474792
http://dx.doi.org/10.20524/aog.2019.0405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686093/
https://www.ncbi.nlm.nih.gov/pubmed/31474792
http://dx.doi.org/10.20524/aog.2019.0405

Ejemplares similares